These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6271778)

  • 1. Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D).
    Lamp SJ; Findlay DM; Moseley JM; Martin TJ
    J Biol Chem; 1981 Dec; 256(23):12269-74. PubMed ID: 6271778
    [No Abstract]   [Full Text] [Related]  

  • 2. Homologous desensitization of calcitonin receptors and calcitonin-dependent adenylate cyclase in T47D cells.
    Schneider HG; Raue F; Koppold A; Ruf W; Ziegler R
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):373-8. PubMed ID: 8388616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calcitonin receptor on T 47D breast cancer cells. Evidence for glycosylation.
    Moseley JM; Findlay DM; Gorman JJ; Michelangeli VP; Martin TJ
    Biochem J; 1983 Jun; 212(3):609-16. PubMed ID: 6309149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pertussis toxin on adenylate cyclase responses to prostaglandin E2 and calcitonin in human breast cancer cells.
    Michelangeli VP; Livesey SA; Martin TJ
    Biochem J; 1984 Dec; 224(2):371-7. PubMed ID: 6097215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.
    Findlay DM; Michelangeli VP; Orlowski RC; Martin TJ
    Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new in vitro bioassay for human calcitonin: validation and comparison to the rat hypocalcemia bioassay.
    Grauer A; Raue F; Reinel HH; Schneider HG; Schroth J; Kabay A; Brügger P; Ziegler R
    Bone Miner; 1992 Apr; 17(1):65-74. PubMed ID: 1316197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.
    Findlay DM; Michelangeli VP; Eisman JA; Frampton RJ; Moseley JM; MacIntyre I; Whitehead R; Martin TJ
    Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of adrenomedullin with calcitonin receptor in cultured human breast cancer cells, T 47D.
    Disa J; Dang K; Tan KB; Aiyar N
    Peptides; 1998; 19(2):247-51. PubMed ID: 9493856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells.
    Ng KW; Livesey SA; Larkins RG; Martin TJ
    Cancer Res; 1983 Feb; 43(2):794-800. PubMed ID: 6184157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of adenylate cyclase in a mammary carcinoma cell line by human corticosteroid-binding globulin.
    Nakhla AM; Khan MS; Rosner W
    Biochem Biophys Res Commun; 1988 Jun; 153(3):1012-8. PubMed ID: 2839166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line.
    Findlay DM; deLuise M; Michelangeli VP; Martin TJ
    J Endocrinol; 1981 Feb; 88(2):271-81. PubMed ID: 6259268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in rat brain calcitonin binding sites and adenylyl-cyclase activity during ageing.
    Villa I; Guidobono F; Netti C; Pecile A; Giovanazzi S; Nicosia S
    Neuroreport; 1992 Jul; 3(7):601-4. PubMed ID: 1384767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin receptors in a cloned human breast cancer cell line (MCF 7).
    Martin TJ; Findlay DM; MacIntyre I; Eisman JA; Michelangeli VP; Moseley JM; Partridge NC
    Biochem Biophys Res Commun; 1980 Sep; 96(1):150-6. PubMed ID: 6254504
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
    D'Santos CS; Gatti A; Poyner DR; Hanley MR
    Mol Pharmacol; 1992 May; 41(5):894-9. PubMed ID: 1375316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin binding and degradation by two cultured human breast cancer cell lines (MCF 7 and T 47D).
    Findlay DM; Michelangeli VP; Moseley JM; Martin TJ
    Biochem J; 1981 May; 196(2):513-20. PubMed ID: 7316992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of selective activation of cyclic AMP-dependent protein kinase isoenzymes by calcitonin and prostaglandin E2 in human breast cancer cells.
    Livesey SA; Collier G; Zajac JD; Kemp BE; Martin TJ
    Biochem J; 1984 Dec; 224(2):361-70. PubMed ID: 6596096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calcitonin receptor: characterization and processing.
    Raue F; Schneider HG; Ziegler R
    Prog Clin Biol Res; 1990; 332():67-79. PubMed ID: 2158663
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells.
    Michelangeli VP; Findlay DM; Moseley JM; Martin TJ
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):129-41. PubMed ID: 6315797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line.
    Hunt NH; Ellison M; Underwood JC; Martin TJ
    Br J Cancer; 1977 Jun; 35(6):777-84. PubMed ID: 194616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between internalization and calcitonin-induced receptor loss in T 47D cells.
    Findlay DM; Martin TJ
    Endocrinology; 1984 Jul; 115(1):78-83. PubMed ID: 6329663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.